$BBAI
BigBear.ai Holdings Inc Stock $bbai

$bbai Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000162828024022622 Filed on May 10, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q1
Revenue	$39.78M	$33.12M	$42.15M
YoY Change	3.44%	-21.43%	15.84%
Cost Of Revenue	$28.72M	$26.14M	$31.94M
YoY Change	-2.63%	-18.18%	20.43%
Gross Profit	$11.06M	$6.986M	$10.21M
YoY Change	23.43%	-31.6%	3.51%
Gross Profit Margin	27.81%	21.09%	24.23%
Selling, General & Admin	$23.36M	$16.95M	$20.36M
YoY Change	38.0%	-16.77%	-7.53%
% of Gross Profit	211.19%	242.6%	199.37%
Research & Development	$3.565M	$1.144M	$1.128M
YoY Change	60.22%	1.42%	-60.75%
% of Gross Profit	32.22%	16.38%	11.04%
Depreciation & Amortization	$2.907M	$2.439M	$1.986M
YoY Change	46.89%	22.81%	12.08%
% of Gross Profit	26.28%	34.91%	19.45%
Operating Expenses	$26.93M	$18.09M	$21.49M
YoY Change	40.58%	-15.81%	-13.67%
Operating Profit	-$16.67M	-$98.07M	-$11.28M
YoY Change	63.16%	769.64%	-31.35%
Interest Expense	$4.331M	-$27.55M	-$14.12M
YoY Change	-164.83%	95.05%	-497.27%
% of Operating Profit
Other Income/Expense, Net	$617.0K	$455.0K	$0.00
YoY Change			-100.0%
Pretax Income	-$11.72M	-$125.2M	-$26.16M
YoY Change	-30.63%	378.54%	39.51%
Income Tax	$15.00K	-$14.00K	$59.00K
% Of Pretax Income
Net Earnings	-$11.74M	-$125.1M	-$26.21M
YoY Change	-30.53%	377.41%	39.25%
Net Earnings / Revenue	-29.5%	-377.85%	-62.19%
Basic Earnings Per Share	-$0.05	-$0.67	-$0.19
Diluted Earnings Per Share	-$0.05	-$0.67	-$0.19
COMMON SHARES
Basic Shares Outstanding	246.1M shares	242.6M shares	141.5M shares
Diluted Shares Outstanding	246.3M shares	187.3M shares	138.5M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$72.27M	$81.41M	$21.83M
YoY Change	141.51%	272.99%	-63.61%
Cash & Equivalents	$72.27M	$81.41M	$21.83M
Short-Term Investments
Other Short-Term Assets	$4.519M	$4.661M	$8.775M
YoY Change	-10.37%	-46.88%	32.93%
Inventory
Prepaid Expenses
Receivables	$33.94M	$36.58M	$35.11M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$111.8M	$125.0M	$65.71M
YoY Change	56.15%	90.29%	-31.65%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.586M	$1.570M	$5.799M
YoY Change	32.28%	-72.93%	334.38%
Goodwill	$118.6M	$119.8M	$48.68M
YoY Change	143.66%	146.02%	-46.87%
Intangibles	$118.2M	$120.4M	$83.82M
YoY Change	44.23%	43.7%	2.24%
Long-Term Investments
YoY Change
Other Assets	$1.089M	$1.107M	$560.0K
YoY Change	132.2%	97.68%	-24.43%
Total Long-Term Assets	$249.1M	$252.6M	$138.9M
YoY Change	82.31%	81.91%	-20.96%
TOTAL ASSETS
Total Short-Term Assets	$111.8M	$125.0M	$65.71M
Total Long-Term Assets	$249.1M	$252.6M	$138.9M
Total Assets	$360.9M	$377.6M	$204.6M
YoY Change	73.32%	84.6%	-24.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$7.128M	$6.215M	$10.51M
YoY Change	-2.33%	-40.85%	58.61%
Accrued Expenses	$20.38M	$21.52M	$19.08M
YoY Change	30.36%	12.76%	11.96%
Deferred Revenue	$3.496M	$3.853M	$2.347M
YoY Change	74.8%	64.17%	-15.94%
Short-Term Debt	$0.00	$0.00	$1.296M
YoY Change	-100.0%	-100.0%
Long-Term Debt Due	$417.0K	$826.0K	$1.296M
YoY Change	-20.11%	-36.27%	-57.84%
Total Short-Term Liabilities	$53.32M	$63.07M	$60.84M
YoY Change	-25.73%	3.67%	101.74%
LONG-TERM LIABILITIES
Long-Term Debt	$195.3M	$194.8M	$192.8M
YoY Change	1.01%	1.01%	1.02%
Other Long-Term Liabilities	$9.562M	$0.00	$4.906M
YoY Change		-100.0%	1330.32%
Total Long-Term Liabilities	$195.3M	$194.8M	$197.7M
YoY Change	1.01%	-1.49%	3.41%
TOTAL LIABILITIES
Total Short-Term Liabilities	$53.32M	$63.07M	$60.84M
Total Long-Term Liabilities	$195.3M	$194.8M	$197.7M
Total Liabilities	$258.1M	$269.1M	$258.6M
YoY Change	-4.32%	4.08%	16.61%
SHAREHOLDERS EQUITY
Retained Earnings	-$450.3M	-$438.6M	-$279.3M
YoY Change	52.04%	57.04%	85.92%
Common Stock	$610.4M	$604.4M	$282.6M
YoY Change	109.08%	113.88%	9.69%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$102.8M	$108.5M	-$54.04M
YoY Change
Total Liabilities & Shareholders Equity	$360.9M	$377.6M	$204.6M
YoY Change	73.32%	84.6%	-24.74%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	-$11.74M	-$125.1M	-$26.21M
YoY Change	-30.53%	377.41%	39.25%
Depreciation, Depletion And Amortization	$2.907M	$2.439M	$1.986M
YoY Change	46.89%	22.81%	12.08%
Cash From Operating Activities	-$7.058M	-$14.36M	-$12.02M
YoY Change	-44.84%	19.49%	59.61%
INVESTING ACTIVITIES
Capital Expenditures	$1.711M	$38.00K	$0.00
YoY Change	85450.0%		-100.0%
Acquisitions		-$13.94M	$0.00
YoY Change
Other Investing Activities	$0.00	$13.94M
YoY Change
Cash From Investing Activities	-$1.711M	$12.25M	$0.00
YoY Change	85450.0%		-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-377.0K	$50.96M	21.21M
YoY Change	-101.8%	140.24%	-120.78%
NET CHANGE
Cash From Operating Activities	-7.058M	-$14.36M	-12.02M
Cash From Investing Activities	-1.711M	$12.25M	0.000
Cash From Financing Activities	-377.0K	$50.96M	21.21M
Net Change In Cash	-9.146M	$48.86M	9.195M
YoY Change	-212.97%	431.32%	-108.36%
FREE CASH FLOW
Cash From Operating Activities	-$7.058M	-$14.36M	-$12.02M
Capital Expenditures	$1.711M	$38.00K	$0.00
Free Cash Flow	-$8.769M	-$14.40M	-$12.02M
YoY Change	-31.48%	19.81%	52.35%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	0	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	0	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1107000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	372000	usd
CY2024Q1	us-gaap	Assets Assets	377627000	usd
CY2023Q4	us-gaap	Assets Assets	199910000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	6215000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	11038000	usd
CY2024Q1	us-gaap	Debt Current DebtCurrent	826000	usd
CY2023Q4	us-gaap	Debt Current DebtCurrent	1229000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	16233000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3853000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	879000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	848000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	779000	usd
CY2024Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	24956000	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	37862000	usd
CY2024Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	4856000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	602000	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	157287522	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	157287522	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	25000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	17000	usd
CY2024Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	604384000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	303428000	usd
CY2024Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	9952803	shares
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	9952803	shares
CY2024Q1	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	57350000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	42154000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	21516000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	63070000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	68622000	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	194761000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	194273000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	11300000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4313000	usd
CY2024Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	14000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	37000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	0	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	0	usd
CY2024Q1	us-gaap	Liabilities Liabilities	269145000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	267245000	usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	57350000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-438577000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-313430000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	108482000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-67335000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	377627000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	199910000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-26214000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3805000	usd
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	246061379	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	246061379	shares
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	16948000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	20362000	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1144000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1128000	usd
CY2024Q1	us-gaap	Restructuring Charges RestructuringCharges	860000	usd
CY2023Q1	us-gaap	Restructuring Charges RestructuringCharges	755000	usd
CY2024Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	1103000	usd
CY2023Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0	usd
CY2024Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	85000000	usd
CY2023Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-98069000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-12032000	usd
CY2024Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	3555000	usd
CY2023Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	3556000	usd
CY2024Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-23992000	usd
CY2023Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-10567000	usd
CY2024Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	455000	usd
CY2023Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	0	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-125161000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-26155000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-14000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	59000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-125147000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-26214000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.67
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.19
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.67
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.19
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	187279204	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	138548599	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	187279204	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	138548599	shares
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-67335000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-125147000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5157000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	86000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	207776000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-2762000	usd
CY2024Q1	bbai	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	90707000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	108482000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-37872000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-839000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-125147000	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2439000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1986000	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	506000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	500000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	5157000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	3805000	usd
CY2024Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	85000000	usd
CY2023Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2024Q1	bbai	Operating Lease Noncash Lease Expense OperatingLeaseNoncashLeaseExpense	94000	usd
CY2023Q1	bbai	Operating Lease Noncash Lease Expense OperatingLeaseNoncashLeaseExpense	-35000	usd
CY2024Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	171000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	882000	usd
CY2024Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-23000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	54000	usd
CY2024Q1	bbai	Fair Value Adjustments Of Warrants And Derivatives FairValueAdjustmentsOfWarrantsAndDerivatives	23992000	usd
CY2023Q1	bbai	Fair Value Adjustments Of Warrants And Derivatives FairValueAdjustmentsOfWarrantsAndDerivatives	10567000	usd
CY2024Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-8000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	8957000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3469000	usd
CY2024Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-2443000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	1115000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-950000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1488000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-5960000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-4914000	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2599000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	4066000	usd
CY2024Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1826000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	325000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	551000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	49000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-14359000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12017000	usd
CY2024Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-13935000	usd
CY2023Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	38000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	usd
CY2024Q1	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	1643000	usd
CY2023Q1	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	0	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	12254000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
CY2024Q1	bbai	Proceeds From Issuance Of Shares For Exercised Rdo And Pipe Warrants ProceedsFromIssuanceOfSharesForExercisedRDOAndPIPEWarrants	53809000	usd
CY2023Q1	bbai	Proceeds From Issuance Of Shares For Exercised Rdo And Pipe Warrants ProceedsFromIssuanceOfSharesForExercisedRDOAndPIPEWarrants	0	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	0	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	25000000	usd
CY2024Q1	bbai	Payments For Repurchase Of Private Placement And Registered Direct Offering Transaction Costs PaymentsForRepurchaseOfPrivatePlacementAndRegisteredDirectOfferingTransactionCosts	0	usd
CY2023Q1	bbai	Payments For Repurchase Of Private Placement And Registered Direct Offering Transaction Costs PaymentsForRepurchaseOfPrivatePlacementAndRegisteredDirectOfferingTransactionCosts	3025000	usd
CY2024Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	403000	usd
CY2023Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	763000	usd
CY2024Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	86000	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
CY2024Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2532000	usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	50960000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	21212000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	48855000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	9195000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	32557000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12632000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	81412000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21827000	usd
CY2024Q1	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	207776000	usd
CY2023Q1	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	0	usd
CY2022	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2023Q4	us-gaap	Goodwill Goodwill	48683000	usd
CY2024Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	85000000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	119769000	usd
CY2024Q1	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	138544000	usd
CY2024Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	85000000.0	usd
CY2024Q1	bbai	Goodwill Impairment Test Discount Rate GoodwillImpairmentTestDiscountRate	0.31
CY2024Q1	bbai	Goodwill Impairment Test Excess Fair Value Over Carrying Value GoodwillImpairmentTestExcessFairValueOverCarryingValue	0	usd
CY2024Q1	us-gaap	Prepaid Insurance PrepaidInsurance	1040000	usd
CY2024Q1	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	145372000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	24928000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	120444000	usd
CY2023Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	104628000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	22588000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	82040000	usd
CY2024Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	0	usd
CY2023	us-gaap	Adjustment For Amortization AdjustmentForAmortization	0	usd
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2339000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1868000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	11971000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	16137000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	15154000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	13258000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	7184000	usd
CY2024Q1	bbai	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	56740000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	120444000	usd
CY2023Q4	us-gaap	Prepaid Insurance PrepaidInsurance	1419000	usd
CY2024Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	1840000	usd
CY2023Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	1246000	usd
CY2024Q1	us-gaap	Prepaid Taxes PrepaidTaxes	1781000	usd
CY2023Q4	us-gaap	Prepaid Taxes PrepaidTaxes	1784000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4661000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4449000	usd
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	11885000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	10118000	usd
CY2024Q1	us-gaap	Interest Payable Current InterestPayableCurrent	3559000	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	560000	usd
CY2024Q1	bbai	Legal Accruals Current LegalAccrualsCurrent	3003000	usd
CY2023Q4	bbai	Legal Accruals Current LegalAccrualsCurrent	1253000	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3069000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	4302000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	21516000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	16233000	usd
CY2024Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	200826000	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	201229000	usd
CY2024Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	5239000	usd
CY2023Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	5727000	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	195587000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	195502000	usd
CY2024Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	826000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1229000	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	194761000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	194273000	usd
CY2024Q1	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	200000000	usd
CY2022Q4	bbai	Line Of Credit Facility Covenant Ability To Borrow Minimum Required Adjusted Ebitda For Two Preceding Quarters LineOfCreditFacilityCovenantAbilityToBorrowMinimumRequiredAdjustedEBITDAForTwoPrecedingQuarters	1	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	81412000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P5Y
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y2M12D
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y2M19D
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1064
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1050
CY2024Q1	us-gaap	Lease Cost LeaseCost	417000	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	377000	usd
CY2024Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	4000	usd
CY2024Q1	us-gaap	Variable Lease Cost VariableLeaseCost	26000	usd
CY2023Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	63000	usd
CY2023Q1	us-gaap	Variable Lease Cost VariableLeaseCost	22000	usd
CY2024Q1	bbai	Number Of Subleases NumberOfSubleases	2	sublease
CY2023Q1	bbai	Number Of Subleases NumberOfSubleases	3	sublease
CY2024Q1	us-gaap	Sublease Income SubleaseIncome	23000	usd
CY2023Q1	us-gaap	Sublease Income SubleaseIncome	39000	usd
CY2024Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	578000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	325000	usd
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	1790000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	2359000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	2278000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1697000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1671000	usd
CY2024Q1	bbai	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	9076000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	18871000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	6723000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	12148000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	848000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	11300000	usd
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.002
CY2024Q1	us-gaap	Loss Contingency Estimate Of Possible Loss LossContingencyEstimateOfPossibleLoss	1631000	usd
CY2024Q1	us-gaap	Loss Contingency Estimate Of Possible Loss LossContingencyEstimateOfPossibleLoss	1631000	usd
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	246061379	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	157287522	shares
CY2024Q1	bbai	Common Stock Voting Rights Vote For Each Share CommonStockVotingRightsVoteForEachShare	1	vote
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	5127673	shares
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	2.14
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y10D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2209000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	0	shares
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	0
CY2024Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	69171	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.35
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	507749	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.55
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	0	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	4550753	shares
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	2.10
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y2M4D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1733000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1382936	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.35
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P8Y1M28D
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	593000	usd
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5157000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3805000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-125147000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-26214000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	187279204	shares
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	187279204	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	138548599	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	138548599	shares
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.67
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.67
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.19
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.19
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	33121000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	42154000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	230000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	98000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	0	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	882000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	59000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	171000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	980000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	33121000	usd
CY2024Q1	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	1
CY2023Q1	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	1
CY2024Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	2379000	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	4822000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3853000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	879000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	879000	usd
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	111000000	usd
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	1
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M

Files In Submission

Name	View Source	Status
0001628280-24-022622-index-headers.html	Edgar Link	pending
0001628280-24-022622-index.html	Edgar Link	pending
0001628280-24-022622.txt	Edgar Link	pending
0001628280-24-022622-xbrl.zip	Edgar Link	pending
bbai-20240331.htm	Edgar Link	pending
bbai-20240331.xsd	Edgar Link	pending
bbai-20240331_lab.xml	Edgar Link	unprocessable
bbai-20240331_htm.xml	Edgar Link	completed
bigbear-lw51opinionexecu.htm	Edgar Link	pending
bigbear-lw51opinionexecu001.jpg	Edgar Link	pending
bigbear-lw51opinionexecu002.jpg	Edgar Link	pending
exhibit104bigbearatm-sal.htm	Edgar Link	pending
exhibit104bigbearatm-sal001.jpg	Edgar Link	pending
exhibit104bigbearatm-sal002.jpg	Edgar Link	pending
exhibit104bigbearatm-sal003.jpg	Edgar Link	pending
exhibit104bigbearatm-sal004.jpg	Edgar Link	pending
exhibit104bigbearatm-sal005.jpg	Edgar Link	pending
exhibit104bigbearatm-sal006.jpg	Edgar Link	pending
exhibit104bigbearatm-sal007.jpg	Edgar Link	pending
exhibit104bigbearatm-sal008.jpg	Edgar Link	pending
exhibit104bigbearatm-sal009.jpg	Edgar Link	pending
exhibit104bigbearatm-sal010.jpg	Edgar Link	pending
exhibit104bigbearatm-sal011.jpg	Edgar Link	pending
exhibit104bigbearatm-sal012.jpg	Edgar Link	pending
exhibit104bigbearatm-sal013.jpg	Edgar Link	pending
exhibit104bigbearatm-sal014.jpg	Edgar Link	pending
exhibit104bigbearatm-sal015.jpg	Edgar Link	pending
exhibit104bigbearatm-sal016.jpg	Edgar Link	pending
exhibit104bigbearatm-sal017.jpg	Edgar Link	pending
exhibit104bigbearatm-sal018.jpg	Edgar Link	pending
exhibit104bigbearatm-sal019.jpg	Edgar Link	pending
exhibit104bigbearatm-sal020.jpg	Edgar Link	pending
exhibit104bigbearatm-sal021.jpg	Edgar Link	pending
exhibit104bigbearatm-sal022.jpg	Edgar Link	pending
exhibit104bigbearatm-sal023.jpg	Edgar Link	pending
exhibit104bigbearatm-sal024.jpg	Edgar Link	pending
exhibit104bigbearatm-sal025.jpg	Edgar Link	pending
exhibit104bigbearatm-sal026.jpg	Edgar Link	pending
exhibit104bigbearatm-sal027.jpg	Edgar Link	pending
exhibit104bigbearatm-sal028.jpg	Edgar Link	pending
exhibit104bigbearatm-sal029.jpg	Edgar Link	pending
exhibit104bigbearatm-sal030.jpg	Edgar Link	pending
exhibit104bigbearatm-sal031.jpg	Edgar Link	pending
exhibit104bigbearatm-sal032.jpg	Edgar Link	pending
exhibit104bigbearatm-sal033.jpg	Edgar Link	pending
exhibit104bigbearatm-sal034.jpg	Edgar Link	pending
exhibit104bigbearatm-sal035.jpg	Edgar Link	pending
exhibit104bigbearatm-sal036.jpg	Edgar Link	pending
exhibit104bigbearatm-sal037.jpg	Edgar Link	pending
exhibit104bigbearatm-sal038.jpg	Edgar Link	pending
exhibit104bigbearatm-sal039.jpg	Edgar Link	pending
exhibit104bigbearatm-sal040.jpg	Edgar Link	pending
exhibit104bigbearatm-sal041.jpg	Edgar Link	pending
exhibit104bigbearatm-sal042.jpg	Edgar Link	pending
exhibit104bigbearatm-sal043.jpg	Edgar Link	pending
exhibit104bigbearatm-sal044.jpg	Edgar Link	pending
exhibit104bigbearatm-sal045.jpg	Edgar Link	pending
exhibit104bigbearatm-sal046.jpg	Edgar Link	pending
exhibit311-ceocertificatio.htm	Edgar Link	pending
exhibit312-cfocertificatio.htm	Edgar Link	pending
exhibit321-906ceo3312024.htm	Edgar Link	pending
exhibit322-906cfo3312024.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
bbai-20240331_cal.xml	Edgar Link	unprocessable
bbai-20240331_def.xml	Edgar Link	unprocessable
bbai-20240331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BBAI
BigBear.ai Holdings Inc Stock $bbai

2024 Q2 Form 10-Q Financial Statement

#000162828024022622 Filed on May 10, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BBAI BigBear.ai Holdings Inc Stock $bbai

2024 Q2 Form 10-Q Financial Statement

#000162828024022622 Filed on May 10, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BBAI
BigBear.ai Holdings Inc Stock $bbai